Hepatitis C virus non-structural protein 4A (NS4A) (NS4A)

Hepatitis C virus non-structural protein 4A (NS4A) is a small, 54-amino acid polypeptide that serves as an essential cofactor for the NS3 serine protease (UniProt: P26664). It forms a stable heterodimeric complex with NS3, which is required for the protease's stability, proper folding, and localization to the endoplasmic reticulum membrane (PubMed: 10482586). The primary biological role of the NS3/4A complex is the proteolytic processing of the HCV polyprotein at four specific junctions, generating the mature non-structural proteins necessary for viral RNA replication (NIH: NBK11460). Furthermore, NS4A facilitates the virus's ability to evade the host's innate immune system by enabling the cleavage of mitochondrial antiviral-signaling protein (MAVS) and TIR-domain-containing adapter-inducing interferon-beta (TRIF), thereby blocking interferon production (PubMed: 16123306). In clinical practice, the NS3/4A complex is a major target for direct-acting antiviral (DAA) therapy. Drugs such as Glecaprevir and Grazoprevir bind to the protease complex, inhibiting its enzymatic activity and effectively halting the viral life cycle (PubChem: CID 67106744). Resistance to these drugs can emerge through specific mutations in the NS3 or NS4A regions, making it a critical focus for monitoring during treatment.

Other names

NS4AHCV NS4ANon-structural protein 4Ap8

Inhibition of the NS3/4A serine protease complex, which prevents the cleavage of the viral polyprotein into functional non-structural proteins, thereby halting viral replication.